|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1301 Pennsylvania Ave NW |
Address2 | Suite 800 |
City | WASHINGTON |
State | DC |
Zip Code | 20004-1725 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 2811-12
|
||||||||
|
6. House ID# 305490000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul G. Billings, Vice President National Policy & Advocacy |
Date | 07/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Issues related to the health impacts of air pollution, including the following legislation: H.R.2996 Department of the Interior, Environment, and Related Agencies Appropriations Act 2010; HR 2454: American Clean Energy and Security Act, HR 2323 Climate Change Health Protection and Promotion Act;
HR 1835 New Alternative Transportation to Give Americans Solutions Act of 2009; S.1408 New Alternative Transportation to Give Americans Solutions, S.1733 Clean Energy Jobs and American Power Act; S. 1666 To require the Administrator of the Environmental Protection Agency to satisfy certain conditions before issuing to producers of mid-level ethanol blends a waiver from certain requirements under the Clean Air Act, and for other purposes. S.2995 Clean Air Act Amendments of 2010 Clean air issues related to mobile source emissions; diesel retrofits; fuels including alternative fuels; stationary source emissions, including power plants and implementation and enforcement of the Clean Air Act. Issues related to global warming and energy. Issues related to open burning. Air pollution issues related to the oil spill in the Gulf of Mexico.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), Office of Management & Budget (OMB), White House Office, Council on Environmental Quality (CEQ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease, including the following legislation: HR 1619 Children's Health Protection Act of 2009; S 643 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
S. 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S 670 Smoke Free Mothers and Babies Act of 2009; S.914 Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009; HR 1079 Pulmonary Fibrosis Research Enhancement Act; HR 2730 Student-to-School Nurse Ratio Improvement Act of 2009; HR 3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; S. 1577 The Asthma Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 2293 The Public Health Trade Advisory Committee Act; S. 1760 Family Asthma Act; HR 3754 Family Asthma Act; H.Res 919 Supporting the goals and ideals of Chronic Obstructive Pulmonary Disease Awareness Month; S. 2817 A bill to amend part D of title V of the Elementary and Secondary Education Act of 1965 to provide grants to schools for the development of asthma management plans and the purchase of asthma inhalers and spacers for emergency use, as necessary; P.L. 110-233, Genetic Information Nondescrimination Act; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; H.R.4872 Health Care and Education Reconciliation Act of 2010; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to nicotine drug delivery devices; Issues related to drug safety; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to genetic non-discrimination; Issues related to tobacco strategic plan; Issues related to prevention and wellness.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research, public health and clean air including the following legislation: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011;
Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2011; Department of the Interior, Environment, and Related Agencies Appropriations Act 2011; Department of State, Foreign Operations and Related Programs Appropriations Act, 2011; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011; Department of Defense Appropriations Act, 2011; Energy and Water Appropriations Act, 2011; Issues related to economic stimulus.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Environmental Protection Agency (EPA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues related to tobacco use prevention, cessation, secondhand smoke and product regulation including: HR 1261 Youth Prevention and Tobacco Harm Reduction Act; S. 579 Federal Tobacco Act of 2009; HR 1432 Stop Adolescent Smoking Without Excessive Bureaucracy Act of 2009; HR 1850 Quit Smoking for Life Act;
S.770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; HR1400 To amend title 39, United States Code, to make cigarettes and certain other tobacco products nonmailable, and for other purposes; H.R. 1676 Prevent All Cigarette Trafficking Act of 2009; S.1147 Prevent All Cigarette Trafficking Act of 2009; S. 670 Smoke Free Mothers and Babies Act of 2009; HR 2293 The Public Health Trade Advisory Committee Act; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009, HR 3590 The Patient Protection and Affordable Care Act; HR.3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010; HR 3082 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010; HR 2996 Department of the Interior, Environment, and Related Agencies Appropriations Act 2010; HR 3081 Department of State, Foreign Operations and Related Programs Appropriations Act, 2010; HR 2997 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act; S1407 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010; S. 1406 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act; HR 3288 Consolidated Appropriations Act, 2010; HR 4105 Healthy Air for Federal Workers Act; HR 4131 Smoke-Free Federal Workplace Act; H.R.4872 Health Care and Education Reconciliation Act of 2010; S.3288 Smuggled Tobacco Prevention Act of 2010; H.R.5178 Smuggled Tobacco Prevention Act of 2010; Framework Convention on Tobacco Control; Issues related to the FDA regulation of tobacco products; Issues related to tobacco cessation coverage; Issues related to protecting federal workers from secondhand smoke; Issues related to tobacco use and the military; Issues related to tobacco and trade issues; Issues related to smokefree VA facililties; Issues related to smokefree passenger trains; Issues related to tobacco smuggling.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), White House Office, Health & Human Services - Dept of (HHS), U.S. Trade Representative (USTR), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to lung disease including tobacco tax
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease including the following legislation:HR 1619 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act;
HR 332 Lung Cancer Mortality Reduction Act of 2009; HR 2112 Lung Cancer Mortality Reduction Act of 2009; S. 670 Smoke Free Mothers and Babies Act of 2009; HR 3200: America's Affordable Health Choices Act of 2009; S. 1679 Affordable Health Choices Act; S.1796 Americas Healthy Future Act of 2009; HR 3590 The Patient Protection and Affordable Care Act; H.R. 3220 Medicare Home Oxygen Therapy Act of 2009; HR 3790 To amend title XVIII of the Social Security Act to repeal the Medicare competitive acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS) in a budget neutral manner; H.R.4872 Health Care and Education Reconciliation Act of 2010; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis; Issues related to durable medical equipment; Issues related to pulmonary rehabilitation services; Issues related to influenza; Issues related to tobacco cessation services; Issues related to the implementation of the Patient Protection and Affordable Care Act;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues related to smokefree VA facilities; Issues related to exposure to open burning.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
Issues related to non-profit postal rates
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Postal Regulatory Commission, U.S. Postal Service (USPS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Issues related to tobacco use in the military; Issues related to burn pits
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | 1301 Pennsylvania Avenue NW Suite 800 |
||||||
City | Washington |
State | |
Zip Code | 20004-1725 |
Country | |
21. Client new principal place of business (if different than line 20)
City | Washington |
State | |
Zip Code | 20004-1725 |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |